KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Long-Term Investments (2016 - 2025)

Gilead Sciences (GILD) has disclosed Long-Term Investments for 16 consecutive years, with $2.0 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Investments changed N/A year-over-year to $2.0 billion, compared with a TTM value of $2.0 billion through Sep 2025, changed N/A, and an annual FY2023 reading of $1.2 billion, down 6.59% over the prior year.
  • Long-Term Investments was $2.0 billion for Q3 2025 at Gilead Sciences, up from $1.9 billion in the prior quarter.
  • Across five years, Long-Term Investments topped out at $2.0 billion in Q3 2025 and bottomed at $579.0 million in Q1 2021.
  • Average Long-Term Investments over 4 years is $1.3 billion, with a median of $1.3 billion recorded in 2021.
  • Peak annual rise in Long-Term Investments hit 160.76% in 2021, while the deepest fall reached 83.59% in 2021.
  • Year by year, Long-Term Investments stood at $1.3 billion in 2021, then decreased by 4.89% to $1.2 billion in 2022, then decreased by 6.59% to $1.2 billion in 2023, then skyrocketed by 72.4% to $2.0 billion in 2025.
  • Business Quant data shows Long-Term Investments for GILD at $2.0 billion in Q3 2025, $1.9 billion in Q2 2025, and $1.2 billion in Q4 2023.